Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

Published:2018-02-05 Issue:6 Volume:37 Page:1471-1479
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Bae Sang-Cheol,Lee Young Ho

Funder

Korea Healthcare technology R&D Project

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/article/10.1007/s10067-018-4006-5/fulltext.html

Reference40 articles.

1. Felson DT, Anderson JJ, Meenan RF (1990) The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of two meta-analyses. Arthritis Rheum 33(10):1449–1461. https://doi.org/10.1002/art.1780331001

2. Kremer JM (2004) Toward a better understanding of methotrexate. Arthritis Rheum 50(5):1370–1382. https://doi.org/10.1002/art.20278

3. Aletaha D, Smolen JS (2002) The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses. Rheumatology (Oxford) 41(12):1367–1374. https://doi.org/10.1093/rheumatology/41.12.1367

4. Brennan FM, Maini RN, Feldmann M (1992) TNF alpha—a pivotal role in rheumatoid arthritis? Br J Rheumatol 31(5):293–298. https://doi.org/10.1093/rheumatology/31.5.293

5. Lipsky P, van der Heijde D, St Clair E, Furst D, Breedveld F, Kalden J, Smolen J, Weisman M, Emery P, Feldmann M (2000) Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Group. N Engl J Med 343(22):1594–1602. https://doi.org/10.1056/NEJM200011303432202

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developmental drugs for sarcoidosis;Journal of Autoimmunity;2024-03

2. A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis;Arthritis Research & Therapy;2023-10-16

3. Imbalance of Th1 and Th2 cytokines and stem cell therapy in pathological pain;CNS & Neurological Disorders - Drug Targets;2022-12-26

4. Application of IL-6 antagonists in autoimmune disorders;Translational Autoimmunity;2022

5. La réponse aux antagonistes du récepteur de l’interleukine-6 dans la polyarthrite rhumatoïde est indépendante du nombre d’anti-TNF administrés auparavant : revue systématique et méta-analyse;Revue du Rhumatisme;2022-01